Original Research

Safety in Japanese Advanced Breast Cancer Patients Who Received Abemaciclib in MONARCH 2 and MONARCH 3: Assessment of Treatment-Emergent Neutropenia, Diarrhea, and Increased Alanine Aminotransferase and Aspartate Aminotransferase Levels

Masuda N, Chen Y, Kawaguchi T, Dozono K, Toi M

Cancer Management and Research 2022, 14:1179-1194

Published Date: 19 March 2022